THE KOREA REGENERATIVE MEDICINE GUIDE
Evidence
Surrogate markers and biological age claims
A changed test result is not automatically evidence of a longer or healthier life.
“Use this guide to frame clear, indication-specific questions for your specialist consultation.”
PATIENT EVIDENCE & CONSULTATION GUIDE
Category: Evidence · Editorial Review: Updated 20 October 2026 · 3 minute read
What a surrogate marker is
A surrogate marker is a measurement used as a stand-in for a clinical outcome. Researchers may study blood markers, imaging features, or other biological signals because they can be measured sooner than long-term outcomes. The important question is whether a change in that marker reliably predicts a benefit that matters to patients in the specific treatment setting.
Biological age needs careful interpretation
Tests marketed as biological age can measure selected patterns associated with aging. Different tests may use different methods and produce different results. A lower score after an intervention does not by itself demonstrate that the intervention extends life, prevents disease, or reverses aging throughout the body. Ask how the test was validated and what clinical decision its result supports.
Avoid a chain of assumptions
A clinic may argue that a product changes a marker, that the marker is associated with health, and therefore that the product improves health. Each link needs evidence. Association is not enough to establish that deliberately changing the measurement changes the outcome. The result may also reflect variability, other treatments, or ordinary changes over time.
What to ask about a report
Request the actual pre- and post-treatment values, the expected measurement variation, and the evidence connecting the change to meaningful outcomes. Ask whether the same test would be repeated under comparable conditions. Treat the result as one piece of information rather than a verdict that a regenerative procedure has succeeded.
Continue exploring
- Preclinical research: before a treatment reaches people
- Blinding and placebo effects
- Clinical endpoints: what counts as improvement
- Prepare your consultation checklist
Sources & further reading
Read alongside your treating specialist’s advice. Clinical eligibility, exact products and treatment plans require individual assessment.
CONTINUE YOUR PREPARATION
Prepare for your clinical conversation.
Combine the questions in this guide with our 12-point consultation checklist or explore Seoul clinic profiles.
CELLARIUM
Knowledge before possibility.
Cellarium is an independent editorial guide to regenerative medicine and stem cell consultations in South Korea. It does not provide medical advice, diagnosis, or treatment, and is not affiliated with any clinic or hospital.
© 2026 Cellarium — The Korea Regenerative Medicine Guide. Educational reference only; always consult a qualified specialist.